Panaceutics Relocates Operations to Pittsylvania County, Virginia
03/07/2018
“In addition to providing the necessary manufacturing space, logistical support, rapid access to skilled workforce, and capital support, Panaceutics recognized the strong commitment to fostering the growth of innovative companies by the entire region and the Commonwealth of Virginia. As a company, we are extremely excited about the growth possibilities that this investment creates for Panaceutics,” said Mark Montgomery, CEO of Panaceutics.
As an incentive, the Virginia Economic Development Partnership worked with Pittsylvania County, the Danville Regional Foundation, and the Southern Virginia Regional Alliance to secure the project for Virginia. Governor Northam approved a $105,000 grant from the Commonwealth’s Opportunity Fund to assist the County with the project.
In addition, the Virginia Tobacco Region Revitalization Commission approved $405,000 in Tobacco Region Opportunity Funds. Panaceutics is eligible to receive state benefits from the Virginia Enterprise Zone Program, administered by the Virginia Department of Housing and Community Development. The company will also be eligible to receive Sales and Use Tax Exemptions on manufacturing equipment, and funding and services to support the company’s employee training activities will be provided through the Virginia Jobs Investment Program.
The Launch Place, located in Danville, Virginia, initially invested a total of $500,000 to help the start-up. Since that time, the company developed a patented automation and proprietary software platform enabling personalized multi-compound formulations that disrupt the current multiple pill paradigm and revolutionizes how patients receive and practitioners deliver wellness solutions.
Panaceutics’ goal is to enable delivery of personalized nutraceuticals and pharmaceuticals in a wholesome food source. Its product is delivered in custom-made, good-tasting, and easy-to-swallow multi-compound gels in a convenient soft pouch. “Virginia’s business-friendly environment, higher education system, and robust talent pipeline make the Commonwealth an ideal home for entrepreneurs like Panaceutics that are creating valuable, 21st-century jobs,” said Governor Ralph Northam. “I’d like to recognize The Launch Place for fostering an environment that helped Panaceutics reach this impressive level of growth, as well as Pittsylvania County and the Southern Virginia Regional Alliance for their efforts to help this great company thrive in the Commonwealth.”
“Panaceutics’ trajectory is a great testament to Southern Virginia’s pro-business climate and dedication to helping businesses of all sizes flourish, and we are proud to have this young company on the Commonwealth’s corporate roster,” said Secretary of Commerce and Trade Esther Lee. “Virginia’s dynamic research universities, numerous federally-funded facilities, and renowned R&D institutes will help us continue to attract companies of Panaceutics’ caliber that are at the forefront of their industry. We look forward to a long partnership with Panaceutics and thank the company for its commitment to the region and the Commonwealth.”
Project Announcements
AMI Metals Expands Spokane, Washington, Production Operations
06/20/2025
Newly Weds Foods Plans Dyersburg, Tennessee, Production Operations
06/20/2025
Yaskawa American Expands Franklin, Wisconsin, Headquarters Operations
06/19/2025
Cayuga Milk Ingredients Expands Cayuga County, New York, Production Operations
06/19/2025
Gap Upgrades Gallatin, Tennessee, Logistics Operations
06/19/2025
Swiss-Based Galderma Plans Miami, Florida, Headquarters Operations
06/19/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
The New Math Behind Mexico and U.S. Manufacturing Decisions
Q2 2025